NASDAQ
Immune Therapeutics, Inc. (IMUN) has a interest coverage ratio of -9.66x as of Friday, May 29, 2026. This represents a 222.67% decrease compared to its 12-month average of -2.99x. The interest coverage ratio measures how easily a company can pay interest on its outstanding debt from operating earnings.
No price data available for this timeframe.